Fast Track to the NASDAQ In Proteomics SPAC Deal | SPACs Attack

In this episode, Chris Katje covers another significant event this morning's involving ticker $CMII/U (we're still in units). SomaLogic, a proteomics industry leader, is going public with CM Life Sciences II, valuing the company at $1.2 billion. SoftBank Group, T.Rowe Price, Illumina, Novartis Pharma AG, and ARK Invest are all involved in this 375 million dollar pipe deal. The company employs artifacts and machine learning; they are a market leader with over 300 industry partnerships and customers. They have a cutting-edge technology platform that allows them to measure over 7,000 proteins in a single sample. Get 47% off Benzinga PRO➡️ https://benzinga.grsm.io/youtube47 Meet the Hosts: Chris Katje Twitter: https://twitter.com/chriskatje Mitch Hoch Twitter: https://twitter.com/STORYInvestors //////MORE STUFF TO CHECK OUT/////// For a FREE two-week trial of Benzinga Pro➡️https://pro.benzinga.com/?gspk=eW91dHViZXlvdXR1YmU5OQ%3D%3D&gsxid=rPqrMyn8s1e4 Live education at Benzinga Boot Camp➡️http://bit.ly/BZBootCampFeb Benzinga merch➡️https://swag.benzinga.com/ Join Benzinga’s Discord➡️https://discord.com/invite/Sy2UgMPu6u Benzinga’s Premium Newsletters ➡️https://www.benzinga.com/premium/ideas/benzinga-Premium-newsletters/?utm_source=youtube&utm_medium=yt-description Get EXCLUSIVE ACCESS to Benzinga's Premium Products: https://www.benzinga.com/premium-products/ Like the show? Keep up with all Benzinga news! Visit https://www.benzinga.com/ to subscribe to our newsletter Visit https://twitter.com/Benzinga to follow us on Twitter Visit https://www.facebook.com/Benzinga/ to like us on Facebook Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions. #SPACStocks​ #Benzinga​ #CMII #ArkFunds #IlluminaInvest #Nasdaq